DIA Deep Dive: Devices and Diagnostics

New FDA Guidance provides more transparency into the streamlined Humanitarian Use Device application pathway for treatment or diagnosis of rare diseases as part of Agency's larger commitment to smaller patient populations.

Want to learn more?

To learn more about drug-device combination products, attend our upcoming Regulatory Affairs for Combination Products training course or our Combination Products Conference this October!